Ask AI
SAVE Trial
SAVE: Phase I/II Study of Oral Revumenib Plus Decitabine/Cedazuridine and Venetoclax in Cohort of Patients with Newly Diagnosed AML

Released: December 08, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 08, 2025